本页面由Tiger Trade Technology Pte. Ltd.提供服务

武田制药

18.24
+0.06000.33%
成交量:223.30万
成交额:4,064.87万
市值:580.49亿
市盈率:-57.28
高:18.26
开:18.24
低:18.11
收:18.18
52周最高:18.90
52周最低:12.99
股本:31.83亿
流通股本:30.92亿
量比:0.84
换手率:0.07%
股息:0.63
股息率:3.44%
每股收益(TTM):-0.3184
每股收益(LYR):-0.3042
净资产收益率:-2.26%
总资产收益率:2.69%
市净率:1.22
市盈率(LYR):-59.95

数据加载中...

2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/17

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/12/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities